Solventum

Solventum

Global healthcare company: wound care, dental

Commercial Excellence Leader - India

Full-TimeUpdated on 9/30/2026
No salary listed
Expert
Bengaluru, Karnataka, India
Hybrid

Hybrid role in Bangalore; may include up to 20% domestic travel.

About the job

Requirements
  • Ten or more years of progressive leadership experience in Global Capability Centers, shared services, commercial operations, delivery operations, or comparable matrixed service environments.
  • Demonstrated experience standing up, scaling, or materially transforming a Global Capability Center or capability center in India, including hiring, onboarding, stabilization, and service governance.
  • Proven ability to lead cross-functional teams spanning operational delivery, customer relationship management or workflow support, application delivery, data, automation, and artificial intelligence-enabled operations.
  • Experience leading transitions involving knowledge transfer, shadow periods, cutover plans, post-cutover support, and measurable business-continuity controls.
  • Credibility with technical and operational talent, with enough fluency in software delivery, data engineering, automation, workflow orchestration, and artificial intelligence-enabled operations to set standards and make sound resource decisions.
  • Working knowledge of commercial domains such as sales operations, customer relationship management administration, samples management, commercial analytics, service operations, pricing, or contracting.
  • Strong stakeholder management across regions, cultures, time zones, and functions, with the ability to lead through influence and clarify decision rights.
  • Change leadership capability to move a new organization from setup to stable delivery and then into sustained transformation.
Responsibilities
  • Lead the establishment, stabilization, and transformation of Solventum’s Commercial Excellence India capability center.
  • Provide local leadership for a blended India-based team while ensuring transitioned work remains reliable, measurable, and continuously improved.
  • Guide the transition of selected work from Sales Productivity, CRM Administration, PACE, and Samples Management into the India center with disciplined knowledge transfer, service controls, and business continuity.
  • Provide direct people leadership, site stewardship, and delivery health management for India-based talent supporting Commercial Excellence and adjacent Commercial Experience work.
  • Ensure transitioned services are stable, measurable, and supported by clear service-level agreements, escalation paths, quality baselines, capacity plans, and process documentation.
  • Partner with contributing function leaders on priorities, service expectations, process standards, and role-specific performance input.
  • Build an automation- and artificial-intelligence-ready operating model that improves throughput, reduces low-value manual work, and strengthens seller, customer, and patient support outcomes.
  • Build the initial India center structure, leadership rhythm, and staffing model based on approved transition waves and validated business demand.
  • Coordinate the transition of selected work across Sales Productivity, CRM Administration, PACE, and Samples Management, sequencing waves to protect knowledge transfer, quality, and service continuity.
  • Define and operationalize handoffs, service-level agreements, escalation paths, quality checks, coverage windows, and stabilization plans for supported regions.
  • Establish baseline measures for volume, service levels, quality, rework, cycle time, cost, and experience impact before and after transition.
  • Deliver committed 2027 cost and productivity outcomes without measurable degradation to seller, customer, or patient support.
  • Lead process discovery and redesign across transitioned services, prioritizing standardized, high-volume case work and repeatable workflow patterns.
  • Partner with Automation, Insights and Incubation, Information Technology, and contributing functions to build an automation and artificial intelligence enablement roadmap for the center.
  • Convert stable operational work into scalable digital services where appropriate, including robotic process automation, workflow orchestration, agent-assisted execution, self-service, and large language model-embedded support patterns.
  • Drive productivity improvements through case deflection, task elimination, reduced rework, faster throughput, better routing, and disciplined continuous improvement.
  • Mature the center into a source of operational insight, reusable capabilities, and talent development for the broader Commercial Experience and Commercial Excellence ecosystem.
  • Act as the primary local leader and voice for India-based Commercial Excellence talent.
  • Lead hiring, onboarding, engagement, coaching, performance routines, development planning, and retention for the center in partnership with Human Resources and contributing function leaders.
  • Create a cohesive site culture across different disciplines and work types, anchored in service excellence, quality, accountability, and continuous learning.
  • Coordinate across multiple supported functions so the India team operates as one integrated center rather than disconnected work pods.
  • Guide end-to-end transition planning, including work scoping, knowledge capture, shadow periods, cutover, hypercare, and sustained stabilization.
  • Validate readiness thresholds before work moves, including process documentation, volume stability, quality baselines, role clarity, system access, and escalation design.
  • Manage cross-cultural and statutory sensitivities associated with ceded work in partnership with Human Resources, Legal, regional leaders, and Global Business Services governance.
  • Protect service continuity during transition by coordinating with existing vendor, regional, and service delivery plans.
  • Design roles and team structure before placement decisions are finalized, ensuring clear scope and minimal overlap with retained regional, program, or vendor roles.
  • Build a blended talent base spanning operational delivery, customer relationship management support, case management, application development, data engineering, automation, and artificial-intelligence-enabled operations.
  • Match capacity and skills to demand as the center matures, using workforce data and performance insights to improve productivity and resilience.
  • Establish career paths and development routines that make the center a destination for strong, adaptable talent.
  • Steward the center automation and artificial intelligence enablement roadmap in partnership with the relevant functional and technology teams.
  • Create disciplined intake, prioritization, experimentation, and production-readiness practices for automation and artificial-intelligence-enabled workflow improvements.
  • Ensure responsible use of artificial intelligence, including appropriate human oversight, data governance, process controls, and measurable operational value.
  • Use operational metrics and employee feedback to identify recurring friction, manual work, avoidable rework, and opportunities for scalable solutions.
  • Monitor delivery health across transitioned services, including service levels, quality, cost, risk, employee experience, and stakeholder satisfaction.
  • Keep capability-center economics transparent, including cost savings, productivity improvements, and reinvestment opportunities.
  • Operate within agreed Global Business Services host governance and Commercial Excellence decision-right arrangements.
  • Provide clear reporting to Commercial Experience leadership, Global Business Services partners, and contributing function leaders on performance, risks, decisions needed, and value delivered.

About the company

Solventum provides a wide range of healthcare products across four main areas: wound care and surgical supplies, dental and orthodontic tools, health information software, and purification filters for biopharmaceuticals. These products work by combining material science and data science to help hospitals manage patient records, prevent infections during surgery, and filter fluids for medical treatments like dialysis. Unlike many competitors, the company holds a massive portfolio of over 7,300 patents inherited from its history as a 3M division, allowing it to serve over 75% of U.S. hospitals. Its goal is to use this intellectual property and a disciplined business model to find new solutions for healthcare providers and grow within the global medical technology market.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eagan, Minnesota

Founded

2023

Get referred to Solventum

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 organic sales rose 9.5%, and management raised EPS guidance to $7.10-$7.20.
  • Solventum announced HIS separation on August 5, 2026, sharpening its MedTech focus.
  • The $200 million Eagan Innovation Hub supports roughly 20 launches over two years.

What critics are saying

  • Management expects HIS separation to cut margins about 400 basis points after offsets.
  • ERP cutover orders distorted Q2 2026; Q3 growth resets when demand normalizes.
  • Legal costs, restructuring, and separation complexity keep Solventum exposed until 2027-2028 transactions close.

What makes Solventum unique

  • Solventum combines MedSurg, Dental, and clinical workflow assets from 3M’s healthcare spinout.
  • Its 2026 Eagan Innovation Hub concentrates wound care, sterilization, and digital health R&D.
  • The company still sells into over 75% of U.S. hospitals through entrenched workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

↑ 5%

1 year growth

↑ 5%

2 year growth

↑ 9%
Yahoo Finance
Aug 20th, 2026
BrightSpring Health Services posts 23.9% revenue growth as Solventum and Inspire Medical face headwinds

BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.

Yahoo Finance
Aug 11th, 2026
Solventum beats Q2 estimates with $2.21B revenue, raises EPS guidance 10% amid HIS separation

Healthcare solutions provider Solventum reported second quarter revenue of $2.21 billion, up 2.2% year on year and ahead of analyst estimates of $2.15 billion. Non-GAAP profit of $2.55 per share beat consensus estimates by 33.8%. The company announced plans to separate its Health Information Systems business to focus on its MedSurg and Dental segments. Management said the move would allow the HIS unit to pursue AI-driven innovation whilst sharpening Solventum's focus as a pure-play MedTech company. Second quarter results were temporarily boosted by approximately $125 million in advanced orders placed ahead of a major ERP system transition, which management expects to reverse next quarter. The company raised its full-year adjusted EPS guidance to $7.15 at the midpoint, a 10% increase. Solventum is nearing completion of its separation from 3M.

Yahoo Finance
Aug 9th, 2026
Solventum raises 2026 outlook with 9.5% Q2 growth boosted by $125M advanced orders and $100M tariff refund

Solventum exceeded expectations in Q2, posting $2.2 billion in sales with 9.5% organic growth. However, this included roughly $125 million in advanced ERP-related orders and a $100 million tariff refund. Excluding these benefits, organic growth was approximately 4% and adjusted EPS was estimated at $1.73. The company raised its 2026 outlook, now expecting 2.5%–3% organic sales growth, a 22.2%–22.7% operating margin, adjusted EPS of $7.10–$7.20, and free cash flow of $200 million–$300 million. Third-quarter growth is expected to decline temporarily as the advanced orders reverse. Solventum also announced plans to separate its Health Information Systems business through a potential spin-off or sale, aiming to focus on its MedSurg and Dental segments.

PR Newswire
Aug 5th, 2026
Solventum Q2 sales up 9.5%, raises 2026 guidance and plans to separate Health Information Systems unit

Solventum reported second quarter 2026 sales of $2.2 billion, up 2.2% on a reported basis and 9.5% organically. The MedTech company posted GAAP diluted earnings per share of $0.53 and adjusted diluted EPS of $2.55, marking a 50.9% increase. Operating cash flow reached $227 million, whilst free cash flow totalled $144 million. The strong performance was driven by volume and product mix across all segments, including advance orders ahead of ERP cutovers. Solventum announced plans to separate its Health Information Systems business segment as part of its transformation strategy. The company raised its full-year 2026 guidance, increasing organic sales growth to 2.5% to 3.0%, adjusted EPS to $7.10 to $7.20, and free cash flow to $200 million to $300 million.

Yahoo Finance
Aug 2nd, 2026
Solventum appoints Neil Zieselman as chief accounting officer

Solventum has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed Mary Wilcox, who is retiring. Zieselman brings experience from Surgery Partners, Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya. He is a licensed CPA. The company's stock trades at $85.44. It has delivered a 9.5% return over the past week and 19.1% over the past year. For investors, Zieselman's background in healthcare and corporate finance may influence Solventum's financial controls, reporting quality, and regulatory engagement. His approach could shape disclosure practices and capital allocation commentary in future earnings calls. Interest payments are not well covered by earnings, making any changes under the new Chief Accounting Officer particularly important for risk assessment.